AIDS-Related Kaposi Sarcoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

Published

Journal Article

As treatment of HIV has improved, people living with HIV (PLWH) have experienced a decreased risk of AIDS and AIDS-defining cancers (non-Hodgkin's lymphoma, Kaposi sarcoma, and cervical cancer), but the risk of Kaposi sarcoma in PLWH is still elevated about 500-fold compared with the general population in the United States. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AIDS-Related Kaposi Sarcoma provide diagnosis, treatment, and surveillance recommendations for PLWH who develop limited cutaneous Kaposi sarcoma and for those with advanced cutaneous, oral, visceral, or nodal disease.

Full Text

Duke Authors

Cited Authors

  • Reid, E; Suneja, G; Ambinder, RF; Ard, K; Baiocchi, R; Barta, SK; Carchman, E; Cohen, A; Crysler, OV; Gupta, N; Gustafson, C; Hall, A; Johung, KL; Klopp, A; LaCasce, AS; Lin, C; Mehta, A; Menon, MP; Morgan, D; Nathwani, N; Noy, A; Ratner, L; Rizza, S; Rudek, MA; Sanchez, J; Taylor, J; Tomlinson, B; Wang, C-CJ; Yendamuri, S; Dwyer, MA; CGC, ; Freedman-Cass, DA

Published Date

  • February 2019

Published In

Volume / Issue

  • 17 / 2

Start / End Page

  • 171 - 189

PubMed ID

  • 30787130

Pubmed Central ID

  • 30787130

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

International Standard Serial Number (ISSN)

  • 1540-1405

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2019.0008

Language

  • eng